Marketwatch Stocks in the news: RIL, BEML, RCF, SAIL, Ashok Leyland and Adani Green Admin January 4, 2021 Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its COVID-19 vaccine ZyCoV-D. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
